 |
Bipolar Disorder Treatment Market |
Manic disease, often known as Bipolar Disorder Treatment Market, is a brain disorder that affects one's mood, energy level, and other activities.
Manic and depressive episodes are two of the most common episodes of this illness.
The patient's attitude and ability to carry out everyday duties have both changed abruptly.
Bipolar I, bipolar II, cyclothymic, and other described and non-specified bipolar and associated diseases are the four categories of bipolar disorders.
Bipolar Disorder Treatment Market causes mood swings, as well as moments of exceptionally high emotion, erratic sleep habits, and activity levels.
The symptoms, family history, and lifetime history of the patient are used to diagnose bipolar disorder.
For the diagnosis of bipolar disorder, the healthcare provider usually conducts a mental health evaluation.
In 2019, the global bipolar disorder treatment market is predicted to be worth US$ 7,288.3 million, growing at a CAGR of 5.2 percent over the forecast period (2019-2027).
Over the forecast period, the market is expected to grow due to an increase in product approvals and launches.
Key companies are concentrating on expanding their product portfolios by launching and approving new pharmaceuticals for the treatment of bipolar illness, which is projected to propel the bipolar disorder treatment market forward throughout the forecast period.
For example, the US Food and Drug Administration (FDA) approved Allergan plc and Gedeon Richter Plcsupplemental .'s new drug application (NDA) for VRAYLAR (cariprazine), an oral, once-daily atypical antipsychotic drug for expanded use and treatment of depressive episodes associated with bipolar I disorder (bipolar depression) in adults in May 2019.
Furthermore, Procera Health announced the debut of ProceraMood, a non-prescription medicine that provides mood stabilization as well as assistance for balance and tranquility, in May 2016.
Over the projected period, the market is expected to grow due to an increase in mergers, agreements, and collaborations aimed at developing treatments for bipolar illness.
To improve their position in the bipolar disorder treatment market, market players are focusing on inorganic growth tactics such as collaborations and partnerships.
Key Players
Major players operating in the global bipolar disorder treatment market include Takeda Pharmaceutical Company Limited, Pfizer, Inc., Allergan plc, Otsuka Holdings Co. Ltd
0 Comments